Leerink Swann Starts Trius Therapeutics (TSRX) at Outperform, Sees a More than Double
Tweet Send to a Friend
Leerink Swann initiates coverage on Trius Therapeutics (NASDAQ: TSRX) with a Outperform. PT $10.00.
The firm comments, "Lead drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firm comments, "Lead drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
